1937 related articles for article (PubMed ID: 23321213)
21. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
22. Association between BMI and gene expression of anti-Müllerian hormone and androgen receptor in human granulosa cells in women with and without polycystic ovary syndrome.
Nouri M; Aghadavod E; Khani S; Jamilian M; Amiri Siavashani M; Ahmadi S; Asemi Z
Clin Endocrinol (Oxf); 2016 Oct; 85(4):590-5. PubMed ID: 27163385
[TBL] [Abstract][Full Text] [Related]
23. Expressions of aquaporin family in human luteinized granulosa cells and their correlations with IVF outcomes.
Lee HJ; Jee BC; Kim SK; Kim H; Lee JR; Suh CS; Kim SH
Hum Reprod; 2016 Apr; 31(4):822-31. PubMed ID: 26908840
[TBL] [Abstract][Full Text] [Related]
24. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
[TBL] [Abstract][Full Text] [Related]
25. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
[TBL] [Abstract][Full Text] [Related]
26. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D
J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
[TBL] [Abstract][Full Text] [Related]
27. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation.
Willis DS; Watson H; Mason HD; Galea R; Brincat M; Franks S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3984-91. PubMed ID: 9814480
[TBL] [Abstract][Full Text] [Related]
28. Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by abnormally enhanced promoter activity in polycystic ovary syndrome granulosa cells.
Li Y; Wei LN; Liang XY
Fertil Steril; 2011 Jun; 95(7):2354-8, 2358.e1. PubMed ID: 21514585
[TBL] [Abstract][Full Text] [Related]
29. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
30. Anti-Mullerian hormone (AMH) concentration in follicular fluid and mRNA expression of AMH receptor type II and LH receptor in granulosa cells as predictive markers of good buffalo (Bubalus bubalis) donors.
Liang A; Salzano A; D'Esposito M; Comin A; Montillo M; Yang L; Campanile G; Gasparrini B
Theriogenology; 2016 Sep; 86(4):963-970. PubMed ID: 27087535
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
32. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
Wachs DS; Coffler MS; Malcom PJ; Chang RJ
J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
[TBL] [Abstract][Full Text] [Related]
33. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries.
Rice S; Christoforidis N; Gadd C; Nikolaou D; Seyani L; Donaldson A; Margara R; Hardy K; Franks S
Hum Reprod; 2005 Feb; 20(2):373-81. PubMed ID: 15539436
[TBL] [Abstract][Full Text] [Related]
34. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
Eilertsen TB; Vanky E; Carlsen SM
Hum Reprod; 2012 Aug; 27(8):2494-502. PubMed ID: 22693172
[TBL] [Abstract][Full Text] [Related]
35. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
36. Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.
Schipper I; Rommerts FF; Ten Hacken PM; Fauser BC
J Clin Endocrinol Metab; 1997 May; 82(5):1325-31. PubMed ID: 9141511
[TBL] [Abstract][Full Text] [Related]
37. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism.
Froment P; Plotton I; Giulivi C; Fabre S; Khoueiry R; Mourad NI; Horman S; Ramé C; Rouillon C; Grandhaye J; Bigot Y; Chevaleyre C; Le Guevel R; Mallegol P; Andriantsitohaina R; Guerif F; Tamburini J; Viollet B; Foretz M; Dupont J
Hum Reprod; 2022 May; 37(6):1207-1228. PubMed ID: 35459945
[TBL] [Abstract][Full Text] [Related]
38. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
Chen X; Yin M; Ye D; He Y; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
40. Concentrations of anti-Müllerian hormone in fluid from small human antral follicles show a negative correlation with CYP19 mRNA expression in the corresponding granulosa cells.
Eilsø Nielsen M; Rasmussen IA; Fukuda M; Westergaard LG; Yding Andersen C
Mol Hum Reprod; 2010 Sep; 16(9):637-43. PubMed ID: 20064870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
